Gadoteridol
Cat. No.:YN481913
产品名称: | Gadoteridol |
CAS No.: | 120066-54-8 |
Chemical Name: | [10-[2-(hydroxy-κO)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-gadolinium |
Synonyms: | 钆特醇; SQ-32692; Gd-HP-DO3A |
分子量: | 557.68 |
分子式: | C₁₇H₂₈GdN₄O₇ |
SMILES: | CC1O[Gd+3]2([N]3(CC4)CC5=O)([N]6(CC7)CC([O-]2)=O)([N]47CC8=O)([O-]8)([O-]5)[N](CC6)(CC3)C1 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Gadoteridol是一种含钆基的MRI造影剂,用于中枢神经系统成像。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Runge, V.M., Gelblum, D.Y., and Jacobson, S.Gd HP-DO3A—experimental evaluation in brain and renal MRMagn. Reson. Imaging9(1),79-87(1991)
Filippi, M., Boido, M., Pasquino, C., et al.Successful in vivo MRI tracking of MSCs labeled with gadoteridol in a spinal cord Injury experimental modelExp. Neurol.282,66-77(2016)